Chiesi Usa Revenue, Growth & Competitor Profile

DBA CORNERSTONE BIOPHARMA, INC.
DBA CORNERSTONE THERAPEUTICS INC

Company Profile & Annual Report for Chiesi Usa

Access the complete profile.

Chiesi Usa Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	4242 Drugs & Druggists' Sundries Merchant Wholesalers
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 5417 Scientific Research & Development Services
Address	Chiesi Usa, Inc. 175 Regency Woods Place, Suite 600 Cary, NC 27518

Note: Revenues for privately held companies are statistical evaluations.


Chiesi Usa's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Chiesi Usa's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Chiesi Usa is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry, NAICS Code 4242.

Chiesi Usa Annual Revenue and Growth Rate

Chiesi Usa	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Chiesi Usa's revenues are gauged from an analysis of company filings.

Chiesi Usa's Income Statement (based on Industry Averages)

Chiesi Usa P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Chiesi Usa is developing and marketing. Chiesi Usa doesn't have any recent trademark applications, indicating Chiesi Usa is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
RETAVASE cardiovascular agents for medical purposes, namely, a recombinant plasminogen activator compound for use in the management of acute myocardial infarction	03/15/2019
ZYFLO CONNECT Administration of patient reimbursement programs	11/20/2014
CORNERSTONE CAREDIRECT Charitable services, namely, patient assistance program to provide drugs free of charge to low-income patients without prescription drug coverage	08/07/2013

See all trademarks and details in the Full Report.

Market Share of Chiesi Usa's Largest Competitors

A competitive analysis shows these companies are in the same general field as Chiesi Usa, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AMERISOURCEBERGEN	Conshohocken, PA	100
MCKESSON	Irving, TX	58
CARDINAL HEALTH 119	Dublin, OH	42
TAKEDA PHARMACEUTICALS AMERICA	Lexington, MA	31
CATALENT PHARMA SOLUTIONS	Somerset, NJ	13
OWENS & MINOR DISTRIBUTION	Mechanicsville, VA	11
J M SMITH	Spartanburg, SC	3
DAIICHI SANKYO	Basking Ridge, NJ	3
HIKMA PHARMACEUTICALS USA	Berkeley Heights, NJ	2

Nearby Competitors

These companies are similar in business line and location to Chiesi Usa. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
CHIESI USA	Cary, NC	100
WE PHARMA	Morrisville, NC	13
WE PHARMA DBA WEP CLINICAL	Morrisville, NC	4
TENAX THERAPEUTICS	Chapel Hill, NC	2
UNITED DRUG SUPPLY	Morrisville, NC	1
WAKE FOREST DRUG	Wake Forest, NC	0

Future Competition: Chiesi Usa's Fastest Growing Competitors

These companies are in the same general field as Chiesi Usa and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)